Evaluation of ultrasound accuracy in thyroid mass measurement and its impact on 131I treatment for Graves’ disease
BackgroundThyroid mass is crucial for 131I treatment of Graves’ disease (GD). However, the accuracy of ultrasound (US) - based thyroid mass measurement remains controversial.MethodsThis retrospective study included patients who underwent thyroid US and CT scans. The differences correlation, and agre...
Saved in:
| Main Authors: | Xiangxiang Li, Xu Han, Nan Liu, Shen Wang, Hongyuan Zheng, Ziyu Ma, Ruiguo Zhang, Qiang Jia, Wei Zheng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1617229/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Count-rate management in 131I SPECT/CT calibration
by: Staffan Jacobsson Svärd, et al.
Published: (2025-01-01) -
Factors Predicting Treatment Failure in Patients Treated with Iodine-131 for Graves′ disease
by: Kuruva Manohar, et al.
Published: (2013-04-01) -
Impact of extrathyroidal autoimmune diseases on clinical features and the efficacy of Iodine‐131 therapy in patients with differentiated thyroid cancer
by: Ya‐hong Long, et al.
Published: (2024-09-01) -
Targeted immunotherapies for Graves’ thyroidal & orbital diseases
by: Alan Chun Hong Lee, et al.
Published: (2025-03-01) -
Iodine-131 Combined With Plasma Exchange Treatment in Graves’ Hyperthyroidism Patients With Severe Liver Injury Whose Average Model for End-Stage Liver Disease Scores >20
by: Xin-Fang Zhu, et al.
Published: (2025-01-01)